PGIM India Mutual Fund today announced the launch of PGIM India Healthcare Fund, an open ended equity scheme investing across equity and equity related securities of healthcare and pharmaceutical companies. The fund is benchmarked against BSE Healthcare TRI.
The New Fund Offer (NFO) opens for subscription on November19, 2024 and closes on December 03, 2024. The scheme re-opens for continuous sale and repurchase on December 11, 2024.
“PGIM India Healthcare Fund provides a compelling opportunity for investors to capitalize on India’s burgeoning healthcare sector which benefits from low cost, innovation, growing awareness for health insurance, rising FDI inflows and growing medical tourism and more. We believe the best investment one can make is in one’s own health. The next best investment is protecting yourself and your family with health/life insurance and investing into healthcare as a segment which is a structural theme,” said Ajit Menon, CEO, PGIM India Asset Management.
“We expect healthcare sector to be a structural beneficiary of the India growth story. The sector is likely to witness multiple tailwinds like stable and growing domestic demand, strong pricing power, superior exports potential due to India’s competitive advantage and China +1 strategy being pursued by global pharma,” said Vinay Paharia, CIO, PGIM India Asset Management.